Clinical Trial Update: Registry for Pulmonary Hypertension in China

View source ↗

Summary

An update on the Registry for Pulmonary Hypertension in China; the trial status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Thromboembolic Pulmonary Hypertension

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension | Status: UNKNOWN